mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |